Life Science

A natural metabolite formed by CYP450-mediated hydroxylation followed by catechol-O-methyltransferase (COMT) methylation of estradiol has anticancer agent activity as an angiogenesis inhibitor via the HIF-1&alpha pathway levels are significantly

A natural metabolite formed by CYP450-mediated hydroxylation followed by catechol-O-methyltransferase (COMT) methylation of estradiol has anticancer agent activity as an angiogenesis inhibitor via the HIF-1&alpha pathway levels are significantly

A natural metabolite formed by CYP450-mediated hydroxylation followed by catechol-O-methyltransferase (COMT) methylation of estradiol has anticancer agent activity as an angiogenesis inhibitor via the HIF-1&alpha pathway levels are significantly

A synthetic intermediate or building block for drug discovery or pharmaceutical synthesis.

A synthetic intermediate or building block for drug discovery or pharmaceutical synthesis.

A synthetic intermediate or building block for drug discovery or pharmaceutical synthesis.

2-methyl-1,3-Cyclohexanedione is a synthetic intermediate useful for pharmaceutical synthesis.

2-methyl-1,3-Cyclohexanedione is a synthetic intermediate useful for pharmaceutical synthesis.

2-methyl-1,3-Cyclohexanedione is a synthetic intermediate useful for pharmaceutical synthesis.

2-methyl-1,3-Cyclohexanedione is a synthetic intermediate useful for pharmaceutical synthesis.

2-methyl-3-Pyrimidin-2-yl-propionic acid is a synthetic intermediate useful for pharmaceutical synthesis.

2-methyl-3-Pyrimidin-2-yl-propionic acid is a synthetic intermediate useful for pharmaceutical synthesis.